ResMed Inc. (ASX:RMD)
42.26
+0.79 (1.90%)
Sep 5, 2025, 4:10 PM AEST
ResMed Revenue
In the fiscal year ending June 30, 2025, ResMed had annual revenue of $5.15B USD with 9.84% growth. ResMed had revenue of $1.35B in the quarter ending June 30, 2025, with 10.20% growth.
Revenue
$5.15B
Revenue Growth
+9.84%
P/S Ratio
7.82
Revenue / Employee
$485.50K
Employees
10,600
Market Cap
61.40B AUD
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2025 | 5.15B | 461.03M | 9.84% |
Jun 30, 2024 | 4.69B | 462.30M | 10.95% |
Jun 30, 2023 | 4.22B | 644.87M | 18.02% |
Jun 30, 2022 | 3.58B | 381.30M | 11.93% |
Jun 30, 2021 | 3.20B | 239.81M | 8.11% |
Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 23.73B |
Pro Medicus | 212.98M |
Cochlear | 2.34B |
Sonic Healthcare | 9.65B |
Ramsay Health Care | 17.79B |
Ansell | 3.06B |
Telix Pharmaceuticals | 1.01B |
Mesoblast | 26.23M |
ResMed News
- 2 days ago - ResMed Inc (RMD) Launches Global Initiative to Revolutionize Sleep Health Care | RMD stock news - GuruFocus
- 2 days ago - Resmed Launches Sleep Institute to Elevate Sleep Health as a Global Priority - GlobeNewsWire
- 9 days ago - Obstructive Sleep Apnea Expected to Affect Nearly 77 million U.S. Adults by 2050, New Resmed Study Finds - GlobeNewsWire
- 9 days ago - ResMed: A Dividend Opportunity In The MedTech Space As The Company Grows - Seeking Alpha
- 18 days ago - Resmed Announces Election of Nicole Mowad-Nassar to Board of Directors and Upcoming Retirement of Rich Sulpizio - GlobeNewsWire
- 4 weeks ago - How Resmed’s Mick Farrell turned a $7b company into a $62b giant - The Australian Financial Review
- 4 weeks ago - Top 50 High-Quality Dividend Stocks For August 2025 - Seeking Alpha
- 4 weeks ago - ResMed RMD Q4 2025 Earnings Call Transcript - The Motley Fool